These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 3157011)
1. Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. JAMA; 1985 May; 253(17):2483-6. PubMed ID: 3157011 [No Abstract] [Full Text] [Related]
2. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271 [No Abstract] [Full Text] [Related]
3. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum. JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409 [No Abstract] [Full Text] [Related]
4. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495 [No Abstract] [Full Text] [Related]
5. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. JAMA; 1985 Jan; 253(4):483. PubMed ID: 3881605 [No Abstract] [Full Text] [Related]
6. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735 [TBL] [Abstract][Full Text] [Related]
7. Malaria chemoprophylaxis--which drug? Biddulph J P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184 [No Abstract] [Full Text] [Related]
8. Malaria prophylaxis in travelers. Wolff JA; Smith RP J Fam Pract; 1980 Nov; 11(6):879-82. PubMed ID: 7005388 [TBL] [Abstract][Full Text] [Related]
9. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533 [No Abstract] [Full Text] [Related]
10. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988. Hansford CF S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047 [TBL] [Abstract][Full Text] [Related]
11. Fansidar for malaria prophylaxis. Kissane D Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990 [No Abstract] [Full Text] [Related]
12. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. Pearson RD; Hewlett EL Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713 [TBL] [Abstract][Full Text] [Related]
13. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance]. Niklewski G; Landscheidt H; Glasner H Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058 [No Abstract] [Full Text] [Related]
14. Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa. Miller KD; Lobel HO; Pappaioanou M; Patchen LC; Churchill FC J Infect Dis; 1986 Oct; 154(4):689-91. PubMed ID: 3528321 [No Abstract] [Full Text] [Related]
15. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana]. Kupferschmidt HG; Schröder K; Beltzner B Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886 [TBL] [Abstract][Full Text] [Related]
16. A case of fansidar-resistant Plasmodium falciparum from Tanzania. De Geus A; Meuwissen JH; van Rijn A Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245 [No Abstract] [Full Text] [Related]